{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-015722","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.009026+00:00","generated_at":"2026-06-06T16:42:24.000747+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ProKidney releases updated corporate presentation; no specific financial or clinical updates","bullets":["Company filed an updated investor presentation under Item 7.01 for January 2024.","Presentation highlights REACT renal autologous cell therapy for dialysis prevention.","No new financial data, clinical trial results, or guidance changes were disclosed.","Presentation is available on the company's investor relations website."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-015722","json":"https://secwatch.observer/filing/0001193125-24-015722.json","markdown":"https://secwatch.observer/filing/0001193125-24-015722.md","text":"https://secwatch.observer/filing/0001193125-24-015722.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/0001193125-24-015722-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/d182870d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T16:42:24.000747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}